RenovoRx Inc (RNXT)
1.21
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
RenovoRx Cash from Investing (TTM): 2.032M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.032M |
| September 30, 2023 | 5.008M |
| June 30, 2023 | 8.00M |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | -2.032M |
| September 30, 2022 | -5.008M |
| June 30, 2022 | -8.00M |
| March 31, 2022 | -0.015M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-8.00M
Minimum
Jun 2022
8.00M
Maximum
Jun 2023
-0.0019M
Average
-0.0075M
Median
Cash from Investing (TTM) Benchmarks
| Annexon Inc | 70.70M |
| Longeveron Inc | 8.186M |
| MiNK Therapeutics Inc | -0.0736M |
| Adlai Nortye Ltd | 27.30M |
| Telomir Pharmaceuticals Inc | -- |